Supercharged omega-3: DSM files patent on EPA-rich modified microalgae
DSM has developed a recombinant microalgae up to 20 times richer in EPA omega-3s than its host counterpart. Writing in its global patent filing, the ingredients major said such increased levels of eicosapentaenoic acid (EPA) were a result of multiplying the gene encodings responsible for polyunsaturated fatty acid (PUFA) synthase in the cell.
Specifically, it had multiplied the expression level of PFA1, PFA2 and/or PFA2, to produce as many as 10 copies of the gene encodings within the microalgae.
View the complete list of products from Algae
Click here

